[
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05123456",
        "briefTitle": "A Study of Drug X in Advanced Solid Tumors",
        "officialTitle": "A Phase 2 Randomized, Double-Blind Study of Drug X vs Placebo in Patients With Advanced Solid Tumors",
        "acronym": "RESOLVE",
        "organization": {
          "fullName": "Example Pharmaceuticals Inc",
          "class": "INDUSTRY"
        }
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": { "date": "2024-01-15", "type": "ACTUAL" },
        "completionDateStruct": { "date": "2026-12-31", "type": "ESTIMATED" }
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": ["PHASE2"],
        "designInfo": {
          "allocation": "RANDOMIZED",
          "interventionModel": "PARALLEL",
          "primaryPurpose": "TREATMENT",
          "maskingInfo": { "masking": "DOUBLE" }
        },
        "enrollmentInfo": { "count": 200, "type": "ESTIMATED" }
      },
      "conditionsModule": {
        "conditions": ["Solid Tumor", "Advanced Cancer"]
      },
      "armsInterventionsModule": {
        "armGroups": [
          { "label": "Drug X", "type": "EXPERIMENTAL" },
          { "label": "Placebo", "type": "PLACEBO_COMPARATOR" }
        ],
        "interventions": [
          { "type": "DRUG", "name": "Drug X", "description": "100mg daily" }
        ]
      },
      "eligibilityModule": {
        "eligibilityCriteria": "Inclusion: Adults 18+, confirmed solid tumor...",
        "sex": "ALL",
        "minimumAge": "18 Years",
        "maximumAge": "80 Years"
      },
      "outcomesModule": {
        "primaryOutcomes": [
          { "measure": "Overall Response Rate", "timeFrame": "24 weeks" }
        ],
        "secondaryOutcomes": [
          { "measure": "Progression-Free Survival", "timeFrame": "Up to 2 years" }
        ]
      }
    },
    "hasResults": false
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04987654",
        "briefTitle": "BRCA Gene Therapy Study",
        "organization": { "fullName": "NIH", "class": "NIH" }
      },
      "statusModule": {
        "overallStatus": "COMPLETED"
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": ["PHASE1"]
      },
      "conditionsModule": {
        "conditions": ["Hereditary Breast Cancer"]
      }
    },
    "hasResults": true,
    "resultsSection": {
      "participantFlowModule": {
        "groups": [{ "id": "FG000", "title": "Treatment Arm" }]
      }
    }
  }
]
